Cargando…

Tunicamycin as a Novel Redifferentiation Agent in Radioiodine Therapy for Anaplastic Thyroid Cancer

The silencing of thyroid-related genes presents difficulties in radioiodine therapy for anaplastic thyroid cancers (ATCs). Tunicamycin (TM), an N-linked glycosylation inhibitor, is an anticancer drug. Herein, we investigated TM-induced restoration of responsiveness to radioiodine therapy in radioiod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Yoon Ju, Lee, Jae-Eon, Ji, Hyun Dong, Lee, Bo-Ra, Lee, Sang Bong, Kim, Kil Soo, Lee, In-Kyu, Chin, Jungwook, Cho, Sung Jin, Lee, Jaetae, Lee, Sang-Woo, Ha, Jeoung-Hee, Jeon, Yong Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865976/ https://www.ncbi.nlm.nih.gov/pubmed/33499100 http://dx.doi.org/10.3390/ijms22031077

Ejemplares similares

Crushed Gold Shell Nanoparticles Labeled with Radioactive Iodine as a Theranostic Nanoplatform for Macrophage-Mediated Photothermal Therapy
por: Lee, Sang Bong, et al.
Publicado: (2019)

Redifferentiating Thyroid Cancer: Selumetinib-enhanced Radioiodine Uptake in Thyroid Cancer
por: Larson, Steven M., et al.
Publicado: (2017)

Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy
por: Hong, Chae Moon, et al.
Publicado: (2017)

Radioiodine-Refractory Thyroid Cancer: Molecular Basis of Redifferentiation Therapies, Management, and Novel Therapies
por: Aashiq, Mohamed, et al.
Publicado: (2019)

Enhancement of Natural Killer Cell Cytotoxicity by Sodium/Iodide Symporter Gene-Mediated Radioiodine Pretreatment in Breast Cancer Cells
por: Kim, Hae Won, et al.
Publicado: (2013)

An Inverse Agonist of Estrogen-Related Receptor Gamma, GSK5182, Enhances Na(+)/I(−) Symporter Function in Radioiodine-Refractory Papillary Thyroid Cancer Cells
por: Singh, Thoudam Debraj, et al.
Publicado: (2023)

Antiproliferation and Redifferentiation in Thyroid Cancer Cell Lines by Polyphenol Phytochemicals
por: Kang, Hee Joon, et al.
Publicado: (2011)

Genetically engineered suicide gene in mesenchymal stem cells using a Tet-On system for anaplastic thyroid cancer
por: Kalimuthu, Senthilkumar, et al.
Publicado: (2017)

Targeting GLI1 Transcription Factor for Restoring Iodine Avidity with Redifferentiation in Radioactive-Iodine Refractory Thyroid Cancers
por: Oh, Ji Min, et al.
Publicado: (2022)

The Author Response: Antiproliferation and Redifferentiation in Thyroid Cancer Cell Line by Polyphenol Phytochemicals
por: Kang, Hee Joon, et al.
Publicado: (2011)

Clinical outcomes of patients with T4 or N1b well-differentiated thyroid cancer after different strategies of adjuvant radioiodine therapy
por: Jeong, Shin Young, et al.
Publicado: (2019)

New Molecular Targeted Therapy and Redifferentiation Therapy for Radioiodine-Refractory Advanced Papillary Thyroid Carcinoma: Literature Review
por: Wong, Kai-Pun, et al.
Publicado: (2012)

Modulation of EZH2 Activity Induces an Antitumoral Effect and Cell Redifferentiation in Anaplastic Thyroid Cancer
por: de Mello, Diego Claro, et al.
Publicado: (2023)

The combination of ANT2 shRNA and hNIS radioiodine gene therapy increases CTL cytotoxic activity through the phenotypic modulation of cancer cells: combination treatment with ANT2 shRNA and I-131
por: Choi, Yun, et al.
Publicado: (2013)

Dietary Iodine Intake, Therapy with Radioiodine, and Anaplastic Thyroid Carcinoma
por: Besic, Nikola, et al.
Publicado: (2020)

Redifferentiation of BRAF V600E-Mutated Radioiodine Refractory Metastatic Papillary Thyroid Cancer After Treatment With Dabrafenib and Trametinib
por: Jafri, Sabih, et al.
Publicado: (2021)

In Vivo Optical Reporter-Gene-Based Imaging of Macrophage Infiltration of DNCB-Induced Atopic Dermatitis
por: Lee, Sang Bong, et al.
Publicado: (2020)

Fibroblast rejuvenation by mechanical reprogramming and redifferentiation
por: Roy, Bibhas, et al.
Publicado: (2020)

Preliminary study on the efficacy of xerostomia treatment with sialocentesis targeting thyroid disease patients given radioiodine therapy
por: Kim, Euy-Hyun, et al.
Publicado: (2019)

Prognosis of Anaplastic Thyroid Cancer with Distant Metastasis
por: Lee, Jin-Seok, et al.
Publicado: (2022)

Visualizing mast cell migration to tumor sites using sodium iodide symporter of nuclear medicine reporter gene
por: Oh, Seul-Gi, et al.
Publicado: (2023)

PEGylated crushed gold shell-radiolabeled core nanoballs for in vivo tumor imaging with dual positron emission tomography and Cerenkov luminescent imaging
por: Lee, Sang Bong, et al.
Publicado: (2018)

Anaplastic Thyroid Carcinoma Initially Presented with Abdominal Cutaneous Mass and Hyperthyroidism
por: Lim, Kyu-Hyoung, et al.
Publicado: (2010)

Natural Killer Cell (NK-92MI)-Based Therapy for Pulmonary Metastasis of Anaplastic Thyroid Cancer in a Nude Mouse Model
por: Zhu, Liya, et al.
Publicado: (2017)

Theophylline Increases the Uptake of Radioiodine by Mouse Thyroid
por: Lee, Jong Min, et al.
Publicado: (2004)

Tracking dendritic cell migration into lymph nodes by using a novel PET probe (18)F-tetrafluoroborate for sodium/iodide symporter
por: Lee, Sang Bong, et al.
Publicado: (2017)

The Complete Surgical Resection Without the Radiotherapy for a Recurred Anaplastic Ependymoma at the Cervicomedullary Junction
por: Lee, Chang Sun, et al.
Publicado: (2012)

Lipid‐Peptide‐mRNA Nanoparticles Augment Radioiodine Uptake in Anaplastic Thyroid Cancer
por: Li, Qinglin, et al.
Publicado: (2022)

Contrast-enhanced CT-based Radiomics for the Differentiation of Anaplastic or Poorly Differentiated Thyroid Carcinoma from Differentiated Thyroid Carcinoma: A Pilot Study
por: Moon, Jayoung, et al.
Publicado: (2023)

Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
por: Liu, Jierui, et al.
Publicado: (2019)

Radioactive Iodine Resistant Papillary Thyroid Cancer “Redifferentiated” With Dabrafenib
por: Zayouna, Christine, et al.
Publicado: (2021)

Multimodality Imaging of Bone Marrow–Derived Dendritic Cell Migration and Antitumor Immunity()
por: Ahn, Su-Bi, et al.
Publicado: (2017)

Clinical Significance of Observation without Repeated Radioiodine Therapy in Differentiated Thyroid Carcinoma Patients with Positive Surveillance Whole-Body Scans and Negative Thyroglobulin
por: Lim, Dong-Jun, et al.
Publicado: (2010)

New Optical Imaging Reporter-labeled Anaplastic Thyroid Cancer-Derived Extracellular Vesicles as a Platform for In Vivo Tumor Targeting in a Mouse Model
por: Gangadaran, Prakash, et al.
Publicado: (2018)

Microbial copper reduction method to scavenge anthropogenic radioiodine
por: Lee, Seung Yeop, et al.
Publicado: (2016)

Recent Progress of Genome Study for Anaplastic Thyroid Cancer
por: Lee, Jieun, et al.
Publicado: (2013)

Sinomenine Hydrochloride Promotes TSHR-Dependent Redifferentiation in Papillary Thyroid Cancer
por: Zhang, Jing, et al.
Publicado: (2022)

Long-term survival of patients with anaplastic thyroid cancer after multimodal treatment
por: Lee, Haejun, et al.
Publicado: (2020)

Tunicamycin-Induced ER Stress is Accompanied with Oxidative Stress via Abrogation of Sulfur Amino Acids Metabolism in the Liver
por: Kim, Sou Hyun, et al.
Publicado: (2018)

Structure-Based Insight on the Mechanism of N-Glycosylation Inhibition by Tunicamycin
por: Yoon, Danbi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lom5ist22d2jkk7007bvb9nun1